Making CME Matter®
HIV CARE & TREATMENT: ALL THINGS CONSIDERED - Los Angeles CA
Infectious Diseases
Curriculum:
HIV CARE & TREATMENT: ALL THINGS CONSIDERED
HIV CARE & TREATMENT: ALL THINGS CONSIDERED
Credits:
2 ANCC Contact Hours 2 AMA PRA Category 1 Credit(s) ™
2 ANCC Contact Hours 2 AMA PRA Category 1 Credit(s) ™
Launch Date:
June 18, 2014
June 18, 2014
Expiration Date:
The accreditation for this activity has expired.
The accreditation for this activity has expired.
Primary Audience:
Physicians, Nurse Practitioners, Physician Assistants, Registered Nurses, and all interested health care providers involved in the treatment of patients with HIV.
Relevant Terms:
The New Guidelines And The Emergence Of New Agents, Best Practices In The Treatment Of HIV-infected Persons, Conifections, Comorbidities, Initiation Of Treatment, Resistance And Retention.
Donna E. Sweet, MD
Donna E. Sweet, MD
Professor of Medicine
Department of Internal Medicine
University of Kansas School of Medicine
Director, HIV Programs
The Medical Practice Association of the
University of Kansas School of Medicine
Wichita, KS
Bio
Dr. Sweet is Professor of Internal Medicine at the University of Kansas School of Medicine-Wichita. She is Director of Internal Medicine Education at Via Christi Regional Medical Center - St. Francis, as well as the director and principal investigator of the Kansas AIDS Education and Training Center. In addition, she is a past president and current member of the Advisory Board for the Sedgwick County Board of Health. Dr. Sweet is the immediate past Chair of the Board of Regents for The American College of Physicians (ACP), and continues in the organization through her participation on national committees and by working with the College's Eurasian Medical Education program. She has traveled to various parts of the Russian Far East over the past two years providing HIV education to physicians in order to further prevention and treatment efforts there.
Dr. Sweet has been recognized both locally and nationally for treatment and research on HIV/AIDS. She currently serves on the Center for Disease Control/ Health Resource Services Administration's Advisory Council on HIV/AIDS and is a member of the national board for the American Academy of HIV Medicine. In addition, she has served on the planning committee of the National AIDS Update Conference for AmFAR and recently co-chaired The National Ryan White Clinical Update Conference in Washington, D.C.
In 1995, Dr. Sweet was one of only 130 researchers and clinicians nation-wide invited to take part in the first White House Conference on HIV and AIDS. She also received the "Award of Courage" from the American Foundation for AIDS Research on World AIDS Day 1992 and was recognized on World AIDS Day 1993 by the Health Care Financing Administration with an "Administrators Citation" for her willingness to treat HIV infected individuals without regard to their ability to pay. She continues to lecture both locally and nationally to educate other health care providers regarding HIV.
Her role with the Mountain Plains AIDS Education and Training Center takes her across the US delivering HIV prevention and treatment messages. As Clinical Director of the only Ryan White Title III Early Intervention and Treatment Grant in Kansas, she cares for over 850 Kansans with HIV/AIDS.
Charles B. Hicks, MD
Charles B. Hicks, MD
Professor of Clinical Medicine
Medical Director of the Owen Clinic
University of California, San Diego
San Diego, CA
Bio
Charles Hicks, MD, is board-certified in internal medicine and infectious disease. He provides primary care, including preventive care and diagnosis and treatment of acute and chronic diseases for adults with HIV and AIDS. Dr. Hicks is director of UC San Diego Health System's Owen Clinic, one of America's top HIV care programs.
Dr. Hicks is active in infectious disease research with an emphasis on new treatment and medications for individuals with HIV/AIDs. He is widely published in critically reviewed medical journals, including the Journal of Infectious Disease, the American Journal of Medicine, Annals of Internal Medicine, the Journal of American Medical Association, Clinical Infectious Diseases, AIDS and AIDS Research and Human Retroviruses.
As a professor of clinical medicine, Dr. Hicks is involved in training medical students, residents and fellows at UC San Diego School of Medicine.
Prior to joining UC San Diego Health System, Dr. Hicks served as a professor of medicine at Duke University Medical Center. Previously, he was an assistant professor at the Uniformed Services University of Health Sciences and staff physician in infectious disease services at Walter Reed Army Medical Center in Washington, D.C. He also served as chief of the internal medicine clinic at DeWitt Army Community Hospital in Virginia.
Dr. Hicks completed fellowships in infectious disease and medical science at Walter Reed Army Medical Center. He completed his residency and an internship in internal medicine at Letterman Army Medical Center in San Francisco. He received his medical degree from George Washington University and his bachelor's degree from United States Military Academy in West Point, N.Y.
When not at work, Dr. Hicks enjoys spending time with his family (wife Betty Carr and three adult children), cycling, and enjoying a nice glass of wine.
Dr. Hicks is active in infectious disease research with an emphasis on new treatment and medications for individuals with HIV/AIDs. He is widely published in critically reviewed medical journals, including the Journal of Infectious Disease, the American Journal of Medicine, Annals of Internal Medicine, the Journal of American Medical Association, Clinical Infectious Diseases, AIDS and AIDS Research and Human Retroviruses.
As a professor of clinical medicine, Dr. Hicks is involved in training medical students, residents and fellows at UC San Diego School of Medicine.
Prior to joining UC San Diego Health System, Dr. Hicks served as a professor of medicine at Duke University Medical Center. Previously, he was an assistant professor at the Uniformed Services University of Health Sciences and staff physician in infectious disease services at Walter Reed Army Medical Center in Washington, D.C. He also served as chief of the internal medicine clinic at DeWitt Army Community Hospital in Virginia.
Dr. Hicks completed fellowships in infectious disease and medical science at Walter Reed Army Medical Center. He completed his residency and an internship in internal medicine at Letterman Army Medical Center in San Francisco. He received his medical degree from George Washington University and his bachelor's degree from United States Military Academy in West Point, N.Y.
When not at work, Dr. Hicks enjoys spending time with his family (wife Betty Carr and three adult children), cycling, and enjoying a nice glass of wine.
W. David Hardy, MD
W. David Hardy, MD
Professor of Medicine
David Geffen School of Medicine at UCLA
Director, Division of Infectious Diseases
Cedars-Sinai Medical Center
Los Angeles, CA
Bio
W. David Hardy, M.D., is director of infectious diseases at Cedars-Sinai Medical Center in Los Angeles and an associate professor of medicine-in-residence at the David Geffen School of Medicine, University of California, Los Angeles (UCLA). He gained his medical degree from the Baylor College of Medicine in Houston, Texas, in 1981, completed a residency in internal medicine at Harbor-UCLA Medical Center in Torrance, California in 1984 and a clinical fellowship in infectious diseases and immunology in 1986 at UCLA School of Medicine. Later in his career he also completed a postdoctoral fellowship in basic retrovirology in 2002, also at the UCLA School of Medicine. A diplomat of the American Board of Internal Medicine, Dr. Hardy is a member of numerous professional societies including the American Academy of HIV Medicine, for whom he serves as a member of the National Board of Directors and Chairman of the California/Hawaii Chapter. He works with several community organizations, and since 1988 he has been president of the Los Angeles Physicians AIDS Forum, which he co-founded. He has served on the scientific committees for various national and international HIV congresses.
| 1. | Identify for testing all patients in their practices with an unknown HIV status and those at continued high risk for infection | 2. | Utilize data and concepts from clinical studies and evidence-based guidelines to initiate treatment in all HIV-infected patients |
| 3. | Describe how to incorporate new research data and evidence-based guideline recommendations into clinical practice to minimize adverse events and achieve and maintain maximal viral suppression with ART in all HIV-infected patients | 4. | Implement treatment strategies based on clinical data and expert recommendations to treat HIV-infected patients with comorbidities and coinfections |
| 1. | Identify for testing all patients in their practices with an unknown HIV status and those at continued high risk for infection |
| 2. | Utilize data and concepts from clinical studies and evidence-based guidelines to initiate treatment in all HIV-infected patients |
| 3. | Describe how to incorporate new research data and evidence-based guideline recommendations into clinical practice to minimize adverse events and achieve and maintain maximal viral suppression with ART in all HIV-infected patients |
| 4. | Implement treatment strategies based on clinical data and expert recommendations to treat HIV-infected patients with comorbidities and coinfections |
Wednesday, June 18, 2014
McCormick & Schmick’s
Los Angeles, CA
Target Audience
The educational design of this activity addresses the needs of physicians, physician assistants, nurse practitioners, registered nurses, and all interested health care providers involved in the treatment of patients with HIV.
Program Overview
Advances in research and an expansion of antiretroviral therapy (ART) options now enable HIV-infected persons to live near-normal lifespans. However, deficits in quality HIV care from treatment initiation throughout long-term retention persist across the spectrum of care. HIV-infected patients can present significant treatment challenges to health care providers with respect to the initiation of treatment, retention, resistance, coinfections, and comorbidities. The recent approval and anticipated arrival of new agents and new combinations, for both treatment-naive and treatment-experienced patients, as well as newly released HIV professional treatment guidelines, highlight the need for continuing medical education (CME). This CME activity presents best practices in the treatment of HIV-infected persons based on the new guidelines and the emergence of new agents to assist you in making informed care and treatment decisions. In addition, it will provide you with the opportunity to immediately put this new knowledge into virtual clinical practice.
The educational design of this activity addresses the needs of physicians, physician assistants, nurse practitioners, registered nurses, and all interested health care providers involved in the treatment of patients with HIV.
Program Overview
Advances in research and an expansion of antiretroviral therapy (ART) options now enable HIV-infected persons to live near-normal lifespans. However, deficits in quality HIV care from treatment initiation throughout long-term retention persist across the spectrum of care. HIV-infected patients can present significant treatment challenges to health care providers with respect to the initiation of treatment, retention, resistance, coinfections, and comorbidities. The recent approval and anticipated arrival of new agents and new combinations, for both treatment-naive and treatment-experienced patients, as well as newly released HIV professional treatment guidelines, highlight the need for continuing medical education (CME). This CME activity presents best practices in the treatment of HIV-infected persons based on the new guidelines and the emergence of new agents to assist you in making informed care and treatment decisions. In addition, it will provide you with the opportunity to immediately put this new knowledge into virtual clinical practice.
Agenda
7:00 PM – 7:05 PM Welcome and Introduction
7:05 PM – 7:45 PM Overview of Best Practices in HIV Management and Care
7:45 PM – 7:55 PM Question-and-Answer Session
7:55 PM – 8:45 PM Interactive Case Studies7:05 PM – 7:45 PM Overview of Best Practices in HIV Management and Care
7:45 PM – 7:55 PM Question-and-Answer Session
8:45 PM – 9:00 PM Post Program Evaluation
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Global Education Group (Global) and HealthmattersCME. Global is accredited by the ACCME to provide continuing medical education for physicians..
Physician Credit Designation
Global Education Group designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
Global Education Group is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's COA.
This educational activity for 2 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Fee Information & Refund/Cancellation Policy
There is no fee for this educational activity.
For information about the accreditation of this program, please contact Global at 303-395-1782 or inquire@globaleducationgroup.com
Disclosure of Conflicts of Interest
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and HealthmattersCME do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
| Name of Faculty or Presenter | Reported Financial Relationship |
| W. David Hardy, MD | Consultant/Independent Contractor: Boehringer Ingelheim, Bristol-Myers Squibb, Calimmune, Gilead Sciences, Inc., Janssen, ViiV Healthcare Grant/Research Support (To Cedars-Sinai Medical Center): Bionor, Gilead, ViiV Healthcare, Vertex Honoraria: Boerhinger Ingelheim, Bristol-Myers Squibb, Calimmune, Gilead, Janssen, ViiV Healthcare Speaker’s Bureau: ViiV Healthcare Stock Shareholder: Merck |
| Charles Hicks, MD | Consultant/Independent Contractor: Bristol-Myers Squibb; Gilead Sciences, Inc.; Janssen; Merck; ViiV Healthcare |
| Donna E. Sweet, MD | Consultant/Independent Contractor: Pfizer Speaker's Bureau: Bristol-Myers Squibb; Gilead Sciences, Inc. |
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
| Name of Planner or Manager | Reported Financial Relationship |
| Andrea Funk | Nothing to disclose |
| Amanda Glazar, PhD | Nothing to disclose |
| Stacey Hansen | Nothing to disclose |
| Ashley Marostica, RN, MSN | Nothing to disclose |
| James Murphy | Nothing to disclose |
This activity is jointly sponsored by Global Education Group and HealthmattersCME.
This activity is co-provided by Global Education Group and HealthmattersCME.
This activity is supported by an independent educational grant from Gilead Sciences
Medical Affairs.
COURSE VIEWING REQUIREMENTS
This activity is supported by an independent educational grant from Gilead Sciences
Medical Affairs.
COURSE VIEWING REQUIREMENTS
| Supported Browsers: Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8 Google Chrome 28.0+ for Windows, Mac OS, or Linux Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux Safari 5.0+ for Mac OSX 10.5 and above For video playback, install the latest version of Flash or Quicktime. | Supported Phones & Tablets: Android 4.0.3 and above iPhone/iPad with iOS 6.1 or above |
© 2007-2024 HealthCourse, Inc. All rights reserved.
